AMBP and ENO1 |
alpha-1-microglobulin/bikunin precursor |
enolase 1, (alpha) |
- Scavenging of heme from plasma
|
- Gluconeogenesis
- Glucose metabolism
- Myoclonic epilepsy of Lafora
- Glycogen storage diseases
- Glycolysis
- Metabolism of carbohydrates
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
AMFR and BAG6 |
autocrine motility factor receptor, E3 ubiquitin protein ligase |
BCL2-associated athanogene 6 |
|
|
|
|
|
|
BIN1 and RIN2 |
bridging integrator 1 |
Ras and Rab interactor 2 |
|
|
|
|
|
|
ANK3 and HOOK1 |
ankyrin 3, node of Ranvier (ankyrin G) |
hook microtubule-tethering protein 1 |
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
|
|
|
|
|
ANK3 and KCNC1 |
ankyrin 3, node of Ranvier (ankyrin G) |
potassium channel, voltage gated Shaw related subfamily C, member 1 |
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
- Potassium Channels
- Voltage gated Potassium channels
|
|
|
|
|
ANK3 and SPTBN4 |
ankyrin 3, node of Ranvier (ankyrin G) |
spectrin, beta, non-erythrocytic 4 |
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
- NCAM signaling for neurite out-growth
|
|
|
|
|
ANK3 and FADD |
ankyrin 3, node of Ranvier (ankyrin G) |
Fas (TNFRSF6)-associated via death domain |
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
- Regulation by c-FLIP
- Caspase-8 activation by cleavage
- Death Receptor Signalling
- Dimerization of procaspase-8
- TRAIL signaling
- TRIF-mediated TLR3/TLR4 signaling
- FasL/ CD95L signaling
- MyD88-independent cascade
- Activated TLR4 signalling
- RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
- Toll-Like Receptors Cascades
- Toll Like Receptor 3 (TLR3) Cascade
- Toll Like Receptor 4 (TLR4) Cascade
- Programmed Cell Death
- NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
- TRIF-mediated programmed cell death
- Extrinsic Pathway
- Innate Immune System
|
|
|
|
|
ANK3 and SCNN1B |
ankyrin 3, node of Ranvier (ankyrin G) |
sodium channel, non voltage gated 1 beta subunit |
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
- Ion channel transport
- Stimuli-sensing channels
|
|
|
|
|
ANK3 and SMAD2 |
ankyrin 3, node of Ranvier (ankyrin G) |
SMAD family member 2 |
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
- Loss of Function of TGFBR2 in Cancer
- SMAD2/3 MH2 Domain Mutants in Cancer
- Downregulation of TGF-beta receptor signaling
- TGF-beta receptor signaling activates SMADs
- TGFBR1 LBD Mutants in Cancer
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
- Generic Transcription Pathway
- Signaling by NODAL
- TGFBR2 MSI Frameshift Mutants in Cancer
- SMAD2/3 Phosphorylation Motif Mutants in Cancer
- Loss of Function of SMAD2/3 in Cancer
- Signaling by Activin
- TGFBR2 Kinase Domain Mutants in Cancer
- Loss of Function of SMAD4 in Cancer
- TGFBR1 KD Mutants in Cancer
- Loss of Function of TGFBR1 in Cancer
- Signaling by TGF-beta Receptor Complex in Cancer
- Signaling by TGF-beta Receptor Complex
- SMAD4 MH2 Domain Mutants in Cancer
|
|
|
|
|
ANK3 and SMAD3 |
ankyrin 3, node of Ranvier (ankyrin G) |
SMAD family member 3 |
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
- Loss of Function of TGFBR2 in Cancer
- SMAD2/3 MH2 Domain Mutants in Cancer
- Downregulation of TGF-beta receptor signaling
- TGF-beta receptor signaling activates SMADs
- TGFBR1 LBD Mutants in Cancer
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
- Generic Transcription Pathway
- Signaling by NODAL
- TGFBR2 MSI Frameshift Mutants in Cancer
- SMAD2/3 Phosphorylation Motif Mutants in Cancer
- Loss of Function of SMAD2/3 in Cancer
- Signaling by Activin
- TGFBR2 Kinase Domain Mutants in Cancer
- Loss of Function of SMAD4 in Cancer
- TGFBR1 KD Mutants in Cancer
- Loss of Function of TGFBR1 in Cancer
- Signaling by TGF-beta Receptor Complex in Cancer
- Signaling by TGF-beta Receptor Complex
- SMAD4 MH2 Domain Mutants in Cancer
|
|
|
|
|
ANK3 and FAS |
ankyrin 3, node of Ranvier (ankyrin G) |
Fas cell surface death receptor |
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
- Death Receptor Signalling
- FasL/ CD95L signaling
- Programmed Cell Death
- Extrinsic Pathway
|
|
|
|
|
ANK3 and SCN2A |
ankyrin 3, node of Ranvier (ankyrin G) |
sodium channel, voltage gated, type II alpha subunit |
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
|
|
|
|
ANK3 and SCN1B |
ankyrin 3, node of Ranvier (ankyrin G) |
sodium channel, voltage gated, type I beta subunit |
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
|
|
|
|
ANK3 and PIK3R1 |
ankyrin 3, node of Ranvier (ankyrin G) |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
- Signaling by the B Cell Receptor (BCR)
- Signaling by GPCR
- Metabolism of lipids and lipoproteins
- Signaling by FGFR in disease
- Signaling by EGFRvIII in Cancer
- Signaling by SCF-KIT
- Downstream signaling events of B Cell Receptor (BCR)
- DAP12 signaling
- PI3K/AKT activation
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- Interleukin receptor SHC signaling
- PI-3K cascade
- Gastrin-CREB signalling pathway via PKC and MAPK
- Signaling by FGFR1 mutants
- Interleukin-7 signaling
- Role of phospholipids in phagocytosis
- Phospholipid metabolism
- Fcgamma receptor (FCGR) dependent phagocytosis
- PI3K Cascade
- Signaling by PDGF
- DAP12 interactions
- GAB1 signalosome
- G-protein beta:gamma signalling
- CD28 co-stimulation
- CD28 dependent PI3K/Akt signaling
- Signaling by ERBB4
- Constitutive PI3K/AKT Signaling in Cancer
- Role of LAT2/NTAL/LAB on calcium mobilization
- PI3K events in ERBB4 signaling
- G alpha (q) signalling events
- Signaling by ERBB2
- Signaling by EGFR
- GPCR downstream signaling
- Signaling by Interleukins
- TCR signaling
- Signaling by VEGF
- GP1b-IX-V activation signalling
- Downstream signal transduction
- Signaling by FGFR mutants
- Fc epsilon receptor (FCERI) signaling
- Signaling by EGFR in Cancer
- Nephrin interactions
- Interleukin-2 signaling
- PI3K/AKT Signaling in Cancer
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
- Adaptive Immune System
- G alpha (q) signalling events
- Downstream TCR signaling
- Costimulation by the CD28 family
- IRS-mediated signalling
- PIP3 activates AKT signaling
- IGF1R signaling cascade
- VEGFA-VEGFR2 Pathway
- Synthesis of PIPs at the plasma membrane
- IRS-related events triggered by IGF1R
- G beta:gamma signalling through PI3Kgamma
- PI3K events in ERBB2 signaling
- Regulation of signaling by CBL
- Downstream signaling of activated FGFR
- G alpha (12/13) signalling events
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- PI Metabolism
- Innate Immune System
- Signaling by Insulin receptor
- Signalling by NGF
- Insulin receptor signalling cascade
- Cytokine Signaling in Immune system
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- IRS-related events
- NGF signalling via TRKA from the plasma membrane
- Tie2 Signaling
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- Cell surface interactions at the vascular wall
- Signaling by FGFR
- IRS-mediated signalling
- Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
- GPVI-mediated activation cascade
- Interleukin receptor SHC signaling
- Signaling by FGFR1 fusion mutants
- Constitutive Signaling by EGFRvIII
- PI3K Cascade
|
|
- Isoproterenol
- (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE
|
|
|
ANK3 and MAPK6 |
ankyrin 3, node of Ranvier (ankyrin G) |
mitogen-activated protein kinase 6 |
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
|
|
|
|
|
ANXA1 and UNC119 |
annexin A1 |
unc-119 homolog (C. elegans) |
- G alpha (q) signalling events
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- Signaling by GPCR
- Class A/1 (Rhodopsin-like receptors)
- GPCR ligand binding
- Metabolic disorders of biological oxidation enzymes
- Formyl peptide receptors bind formyl peptides and many other ligands
- G alpha (q) signalling events
- GPCR downstream signaling
- Peptide ligand-binding receptors
- Gastrin-CREB signalling pathway via PKC and MAPK
- G alpha (i) signalling events
|
|
- Amcinonide
- Hydrocortisone
- Dexamethasone
|
|
|
|
ANXA1 and S100A11 |
annexin A1 |
S100 calcium binding protein A11 |
- G alpha (q) signalling events
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- Signaling by GPCR
- Class A/1 (Rhodopsin-like receptors)
- GPCR ligand binding
- Metabolic disorders of biological oxidation enzymes
- Formyl peptide receptors bind formyl peptides and many other ligands
- G alpha (q) signalling events
- GPCR downstream signaling
- Peptide ligand-binding receptors
- Gastrin-CREB signalling pathway via PKC and MAPK
- G alpha (i) signalling events
|
|
- Amcinonide
- Hydrocortisone
- Dexamethasone
|
|
|
|
ANXA1 and TGM2 |
annexin A1 |
transglutaminase 2 |
- G alpha (q) signalling events
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- Signaling by GPCR
- Class A/1 (Rhodopsin-like receptors)
- GPCR ligand binding
- Metabolic disorders of biological oxidation enzymes
- Formyl peptide receptors bind formyl peptides and many other ligands
- G alpha (q) signalling events
- GPCR downstream signaling
- Peptide ligand-binding receptors
- Gastrin-CREB signalling pathway via PKC and MAPK
- G alpha (i) signalling events
|
|
- Amcinonide
- Hydrocortisone
- Dexamethasone
|
- Guanosine-5\'-Diphosphate
|
|
|
ANXA1 and KRT8 |
annexin A1 |
keratin 8, type II |
- G alpha (q) signalling events
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- Signaling by GPCR
- Class A/1 (Rhodopsin-like receptors)
- GPCR ligand binding
- Metabolic disorders of biological oxidation enzymes
- Formyl peptide receptors bind formyl peptides and many other ligands
- G alpha (q) signalling events
- GPCR downstream signaling
- Peptide ligand-binding receptors
- Gastrin-CREB signalling pathway via PKC and MAPK
- G alpha (i) signalling events
|
|
- Amcinonide
- Hydrocortisone
- Dexamethasone
|
|
|
|
ANXA1 and UBE2D1 |
annexin A1 |
ubiquitin-conjugating enzyme E2D 1 |
- G alpha (q) signalling events
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- Signaling by GPCR
- Class A/1 (Rhodopsin-like receptors)
- GPCR ligand binding
- Metabolic disorders of biological oxidation enzymes
- Formyl peptide receptors bind formyl peptides and many other ligands
- G alpha (q) signalling events
- GPCR downstream signaling
- Peptide ligand-binding receptors
- Gastrin-CREB signalling pathway via PKC and MAPK
- G alpha (i) signalling events
|
- Loss of Function of TGFBR2 in Cancer
- Phosphorylation of the APC/C
- Negative regulators of RIG-I/MDA5 signaling
- Cellular Senescence
- SMAD2/3 MH2 Domain Mutants in Cancer
- APC/C:Cdc20 mediated degradation of Securin
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- Signaling by BMP
- Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
- Generic Transcription Pathway
- TGFBR2 MSI Frameshift Mutants in Cancer
- SMAD2/3 Phosphorylation Motif Mutants in Cancer
- TRIF-mediated TLR3/TLR4 signaling
- Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
- Loss of Function of SMAD4 in Cancer
- Senescence-Associated Secretory Phenotype (SASP)
- TGFBR1 KD Mutants in Cancer
- APC/C:Cdc20 mediated degradation of mitotic proteins
- Regulation of APC/C activators between G1/S and early anaphase
- APC/C-mediated degradation of cell cycle proteins
- APC/C:Cdc20 mediated degradation of Cyclin B
- Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components
- Toll Like Receptor 3 (TLR3) Cascade
- Toll Like Receptor 4 (TLR4) Cascade
- Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
- APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
- Mitotic Metaphase and Anaphase
- Adaptive Immune System
- Cellular response to hypoxia
- APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
- Antigen processing: Ubiquitination & Proteasome degradation
- Regulation of Hypoxia-inducible Factor (HIF) by oxygen
- Separation of Sister Chromatids
- Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
- Inactivation of APC/C via direct inhibition of the APC/C complex
- Mitotic Anaphase
- TGFBR1 LBD Mutants in Cancer
- M Phase
- Inactivation of APC/C via direct inhibition of the APC/C complex
- Autodegradation of Cdh1 by Cdh1:APC/C
- Mitotic Spindle Checkpoint
- Activated TLR4 signalling
- Class I MHC mediated antigen processing & presentation
- Innate Immune System
- Loss of Function of SMAD2/3 in Cancer
- IKK complex recruitment mediated by RIP1
- TGFBR2 Kinase Domain Mutants in Cancer
- MyD88-independent cascade
- Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components
- Cell Cycle, Mitotic
- Loss of Function of TGFBR1 in Cancer
- RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
- Toll-Like Receptors Cascades
- Signaling by TGF-beta Receptor Complex
- Signaling by TGF-beta Receptor Complex in Cancer
- Regulation of mitotic cell cycle
- Cell Cycle Checkpoints
- SMAD4 MH2 Domain Mutants in Cancer
|
- Amcinonide
- Hydrocortisone
- Dexamethasone
|
|
|
|